Showing results (1131-1140 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|March 25, 2008
A smarter way to manage asthma with a combination of a long-acting beta(2)-agonist and inhaled corticosteroidOlof SelroosTherapeutics and Clinical Risk Management|March 25, 2008
Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromesKavita Raj, Ghulam J MuftiTherapeutics and Clinical Risk Management|March 25, 2008
Role of erlotinib in the management of pancreatic cancerNaureen Starling, John Neoptolemos, David CunninghamTherapeutics and Clinical Risk Management|March 25, 2008
Optimizing use of opiates in the management of cancer painMario Mandalà, Cecilia Moro, Roberto Labianca, et al.Therapeutics and Clinical Risk Management|March 25, 2008
Update on the appropriate use of linezolid in clinical practiceRoberto ManfrediTherapeutics and Clinical Risk Management|March 25, 2008
Restless leg syndrome: is it a real problem?Paul E Cotter, Shaun T O'KeeffeTherapeutics and Clinical Risk Management|October 6, 2016
In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorothiazide, among Palestinian hypertensive patientsAbdel Naser Zaid, Masshour Ghanem, Dua'a Shweiki, et al.Therapeutics and Clinical Risk Management|March 11, 2017
High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinomaNing Na, Heng Li, Chengfang Xu, et al.Therapeutics and Clinical Risk Management|March 19, 2019
Use of National Early Warning Score for observation for increased risk for clinical deterioration during post-ICU care at a surgical wardPia Katrin Klepstad, Trond Nordseth, Normunds Sikora, et al.Therapeutics and Clinical Risk Management|March 19, 2019
Current approaches in the grading and management of cytokine release syndrome after chimeric antigen receptor T-cell therapyLara L Riegler, Gavin P Jones, Daniel W LeePageof 256